44 related articles for article (PubMed ID: 14754605)
1. The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-alpha.
Roman-Gomez J; Jimenez-Velasco A; Castillejo JA; Cervantes F; Barrios M; Colomer D; Heiniger A; Torres A
Haematologica; 2004 Jan; 89(1):42-8. PubMed ID: 14754605
[TBL] [Abstract][Full Text] [Related]
2. SOCS Proteins in Immunity, Inflammatory Diseases, and Immune-Related Cancer.
Sobah ML; Liongue C; Ward AC
Front Med (Lausanne); 2021; 8():727987. PubMed ID: 34604264
[TBL] [Abstract][Full Text] [Related]
3. The Emerging Role of Suppressors of Cytokine Signaling (SOCS) in the Development and Progression of Leukemia.
Keewan E; Matlawska-Wasowska K
Cancers (Basel); 2021 Aug; 13(16):. PubMed ID: 34439155
[TBL] [Abstract][Full Text] [Related]
4. Negative regulators of STAT3 signaling pathway in cancers.
Wu M; Song D; Li H; Yang Y; Ma X; Deng S; Ren C; Shu X
Cancer Manag Res; 2019; 11():4957-4969. PubMed ID: 31213912
[TBL] [Abstract][Full Text] [Related]
5. SOCS1 and its Potential Clinical Role in Tumor.
Ying J; Qiu X; Lu Y; Zhang M
Pathol Oncol Res; 2019 Oct; 25(4):1295-1301. PubMed ID: 30761449
[TBL] [Abstract][Full Text] [Related]
6. Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance.
Budhwani M; Mazzieri R; Dolcetti R
Front Oncol; 2018; 8():322. PubMed ID: 30186768
[TBL] [Abstract][Full Text] [Related]
7. Re-Expression of Bone Marrow Proteoglycan-2 by 5-Azacytidine is associated with STAT3 Inactivation and Sensitivity Response to Imatinib in Resistant CML Cells.
Al-Jamal HAN; Johan MF; Mat Jusoh SA; Ismail I; Wan Taib WR
Asian Pac J Cancer Prev; 2018 Jun; 19(6):1585-1590. PubMed ID: 29936783
[TBL] [Abstract][Full Text] [Related]
8. SOCS1 function in BCR-ABL mediated myeloproliferative disease is dependent on the cytokine environment.
Demirel Ö; Balló O; Reddy PNG; Vakhrusheva O; Zhang J; Eichler A; Fernandes R; Badura S; Serve H; Brandts C
PLoS One; 2017; 12(7):e0180401. PubMed ID: 28753604
[TBL] [Abstract][Full Text] [Related]
9. Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia.
Hou HA; Lu JW; Lin TY; Tsai CH; Chou WC; Lin CC; Kuo YY; Liu CY; Tseng MH; Chiang YC; Peng YL; Tang JL; Gong Z; Lin LI; Tien HF
Blood Cancer J; 2017 Jul; 7(7):e588. PubMed ID: 28753595
[TBL] [Abstract][Full Text] [Related]
10. Global methylation and promoter-specific methylation of the
Martínez-Baños D; Sánchez-Hernández B; Jiménez G; Barrera-Lumbreras G; Barrales-Benítez O
Exp Ther Med; 2017 May; 13(5):2442-2450. PubMed ID: 28565861
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of SOCS-Mediated Negative Feedback of Cytokine Signaling in Carcinogenesis and Its Significance in Cancer Treatment.
Jiang M; Zhang WW; Liu P; Yu W; Liu T; Yu J
Front Immunol; 2017; 8():70. PubMed ID: 28228755
[TBL] [Abstract][Full Text] [Related]
12. Expression of SOCS1 and CXCL12 Proteins in Primary Breast Cancer Are Associated with Presence of Circulating Tumor Cells in Peripheral Blood.
Smolkova B; Mego M; Horvathova Kajabova V; Cierna Z; Danihel L; Sedlackova T; Minarik G; Zmetakova I; Krivulcik T; Gronesova P; Karaba M; Benca J; Pindak D; Mardiak J; Reuben JM; Fridrichova I
Transl Oncol; 2016 Jun; 9(3):184-90. PubMed ID: 27267835
[TBL] [Abstract][Full Text] [Related]
13. The role of small adaptor proteins in the control of oncogenic signalingr driven by tyrosine kinases in human cancer.
Naudin C; Chevalier C; Roche S
Oncotarget; 2016 Mar; 7(10):11033-55. PubMed ID: 26788993
[TBL] [Abstract][Full Text] [Related]
14. The role of suppressors of cytokine signalling in human neoplasms.
Sasi W; Sharma AK; Mokbel K
Mol Biol Int; 2014; 2014():630797. PubMed ID: 24757565
[TBL] [Abstract][Full Text] [Related]
15. SOCS1 prevents graft arteriosclerosis by preserving endothelial cell function.
Qin L; Huang Q; Zhang H; Liu R; Tellides G; Min W; Yu L
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):21-9. PubMed ID: 23994402
[TBL] [Abstract][Full Text] [Related]
16. SOCS proteins in development and disease.
Trengove MC; Ward AC
Am J Clin Exp Immunol; 2013; 2(1):1-29. PubMed ID: 23885323
[TBL] [Abstract][Full Text] [Related]
17. A requirement for SOCS-1 and SOCS-3 phosphorylation in Bcr-Abl-induced tumorigenesis.
Qiu X; Guo G; Chen K; Kashiwada M; Druker BJ; Rothman PB; Chen JL
Neoplasia; 2012 Jun; 14(6):547-58. PubMed ID: 22787435
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma.
Yap J; Salamonsen LA; Jobling T; Nicholls PK; Dimitriadis E
Reprod Biol Endocrinol; 2010 Jun; 8():63. PubMed ID: 20553623
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives.
Vannucchi AM; Guglielmelli P; Rambaldi A; Bogani C; Barbui T
J Cell Mol Med; 2009 Aug; 13(8A):1437-50. PubMed ID: 19522842
[TBL] [Abstract][Full Text] [Related]
20. Suppressor of cytokine signaling (SOCS)-1 is expressed in human prostate cancer and exerts growth-inhibitory function through down-regulation of cyclins and cyclin-dependent kinases.
Neuwirt H; Puhr M; Santer FR; Susani M; Doppler W; Marcias G; Rauch V; Brugger M; Hobisch A; Kenner L; Culig Z
Am J Pathol; 2009 May; 174(5):1921-30. PubMed ID: 19342366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
